Due to the extensions of the Corona measures announced by the Swiss Federal Council, the meeting will take place as a Webinar.

endorsed by:

Swiss Association of the Study of the Liver
Rheuma Schweiz
Center of Human Immunology Lausanne (CHIL)

Promote Interdisciplinarity and Learn from Each Other

After the great success of the meeting last year we are delighted to announce the 2nd Common Ground Meeting on Chronic Inflammation at the Swiss Tech Convention Center on January 28, 2021. This meeting aims at empowering rheumatologists, dermatologists, gastroenterologists, immunologists, nephrologist and pneumologists, internists, and other healthcare professionals to interact and learn from each other in order to advance the care of patients with immune-mediated inflammatory diseases (IMIDs) such as psoriasis, psoriatic arthritis, rheumatoid arthritis, Crohn’s disease, ulcerative colitis, spondylarthritis, hepatitis, interstitial lung disorders, glomerulomephritis, ect. 

  • Discuss and identify common clinical problems and solutions as well as upcoming treatments
  • Share knowledge and experience and foster interdisciplinarity
  • Describe the relationship between the pathophysiology of immune-mediated chronic inflammatory diseases
  • Understand future opportunities and challenges of precision medicine for immune mediated inflammatory diseases across disciplines

We are putting together an exciting program with lectures from leading experts, plenary sessions and enough time for networking and discussions. 

We would be very delighted to seeing you at the face-to-face meeting in Lausanne. Nevertheless, if this might not be possible for you an online transmission will be provided to join the meeting.

Thomas Hügle
Prof. Thomas Hügle
Division of Rheumatology
Michel Gilliet
Prof. Michel Gilliet
Division of Dermatology
Darius Moradpour
Prof. Darius Moradpour
Division of Gastroenterology

Program

(Jan 15, 2021)

09:30
Welcome

Thomas Hügle, Darius Moradpour and Michel Gilliet

Session 1: What’s new on chronic inflammatory conditions in your specialty?

Chairs: Hervé Bachelez, Paris I Camillo Ribi, Lausanne

09:30 – 10:00

Gastroenterology

Markus Neurath, Erlangen

10:00 – 10:30

Rheumatology

Oliver Distler, Zurich

10:30 – 11:00
Pneumology

Christophe von Garnier, Lausanne

Coffee Break
11:10 – 11:40
Dermatology

Alexander Navarini, Basel

11:40 – 12:10
Nephrology

Fadi Fakhouri, Lausanne

Lunch Break

Session 2: Hot topics

COVID-19: Basics and impact on patients with immune-mediated diseases

Chairs: Darius Moradpour I Jacob M. van Laar I Michel Gilliet

12:50 – 13:20

Evolution and dynamics of the SARS-CoV-2 pandemic

Jan Dexler, Berlin

13:20 – 13:50

Controlling cytokine storms at the example of COVID-19

Peter Villiger, Bern

Understanding autoinflammatory diseases

13:50 – 14:20
Inflammasome, Interferopathies & Co

Michaël Hofer, Lausanne

The microbiome and its role in chronic inflammation

 14:20 – 14:50
Mechanisms of host-microbial mutualism

Andrew J. Macpherson, Bern

Coffee Break

Session 3: Interdisciplinary cases

 Chairs:  Alain Schöpfer I Thomas Hügle I Patrick Omoumi I Curdin Conrad

 

15:00 – 15:30

Case 1: Ulcerative colitis, Sweet Syndrome & Arthralgia 

Jonathan Kay, Worcester

15:30 – 16:00
Case 2: New onset
Psoriasis-Arthritis & Crohn

Sarah Kozycki, Lausanne

Conclusion

Invited Faculty

Meet our speakers & chairs

Prof. Oliver Distler
Prof. Oliver Distler

University Hospital Zurich, Switzerland

Biosketch

Oliver Distler is Professor of Rheumatology and Chairman of the Department of Rheumatology at the University of Zurich. He is also heading the Center of Experimental Rheumatology of the University of  Zurich. The Department of Rheumatology has been awarded a EULAR Center of Excellence due to its scientific achievements. With over 300 primary research papers, over 21`000 citations and an HFactor of 73, he is among the top 3 cited researchers worldwide in the field of systemic sclerosis. His
research activities span from a preclinical program focusing on the characterization of key molecules and intracellular signaling cascades driving the disease process to a translational and clinical program with emphasis on precision medicine and phase 2/3 clinical trial design.

Prof. Peter Villiger
Prof. Peter Villiger

University Hospital Bern, Switzerland

Prof. Christophe von Garnier
Prof. Christophe von Garnier

University Hospital Lausanne, Switzerland

Biosketch

Prof von Garnier is a pulmonologist and expert in severe obstructive pulmonary diseases, lung cancer and interventional bronchoscopy.

Prof von Garnier is the chairman of the Division of Respiratory Medicine and full professor at the Lausanne University Hospital (CHUV).

As president of the Swiss Society for Pulmonology, he has been involved in coordinating its response to the SARS-CoV-2 pandemic and is involved in the care of individuals suffering from long-term complications of COVID-19. He has recently published on the management of asthma, COPD, and lung cancer during COVID-19, as well as on pulmonary embolism and respiratory sequelae in COVID-19 patients.

Prof. Jan Felix Drexler
Prof. Jan Felix Drexler

Charité University Hospital Berlin, Germany

Dr. Alain Schöpfer
Dr. Alain Schöpfer

University Hospital Lausanne, Switzerland

Prof. Michaël Hofer
Prof. Michaël Hofer

University Hospital Lausanne , Switzerland

Prof. Hervé Bachelez
Prof. Hervé Bachelez

Saint-Louis University Hospital Paris, France

Biosketch

Professor Bachelez is professor at the Department of Dermatology of the Saint-Louis University Hospital in Paris, France. Since 2004, Professor Bachelez has been full professor of clinical dermatology at the Université Paris-Diderot/Université de Paris, where he received his Ph.D. in immunology in 1999. Professor Bachelez’s clinical and scientific research focuses on immunogenetics of inflammatory skin diseases at the Institut National de la Santé et de la Recherche Médicale (INSERM) at the Imagine Institute in Necker Hospital. His areas of scientific interest include molecular mechanisms of psoriasis and psoriasis-related diseases, and other immune-mediated and inflammatory skin diseases. Professor Bachelez has received several scientific awards, including the Robert Degos award. He is a member of several national and international scientific societies, including the European Academy of Dermatology and Venereology and the European Dermatology Forum (EDF). He is a board member of the International Psoriasis Council, and general secretary-Treasurer-elect of the European Society for Dermatological Research (ESDR).

Professor Bachelez has published more than 230 manuscripts in peer-reviews journals, including the New England Journal of Medicine, The Lancet, Journal of Clinical Investigation, and Arthritis and Rheumatism as leading author.

.

Prof. Fadi Fakhouri
Prof. Fadi Fakhouri

University Hospital Lausanne, Switzerland

Prof. Alexander Navarini
Prof. Alexander Navarini

University Hospital Basel, Switzerland

Dr. Conrad Curdin
Dr. Conrad Curdin

University Hospital Lausanne, Switzerland

Prof. Jonathan Kay
Prof. Jonathan Kay

UMass Memorial Medical Center, Worcester, USA

Prof. Andrew Macpherson
Prof. Andrew Macpherson

University Hospital Bern, Switzerland

Biosketch

Andrew J. Macpherson is Professor of Medicine and Director of Gastroenterology at the University Hospital of Bern, Switzerland. He studied Biochemistry and Medicine at Cambridge University and did his PhD on sugar-proton symport systems in the laboratory of Sir Hans Kornberg and Peter Henderson. His clinical medical studies and clinical speciality training in Gastroenterology were in Cambridge and London. The results (of control experiments) during a project in London on immune-mediated damage to intestinal epithelial cells focused his interest on the way in which the mucosal immune system responds to commensal intestinal microbes. In 1997 he moved to work with Rolf Zinkernagel at the Institute of Experimental Immunology in Zürich. Between 2004 and 2008 he was Farncombe Professor of Medicine and a Canada Research Chair holder at McMaster University in Hamilton.His work has shown that there are different pathways of induction of immunoglobulin (Ig)A in the intestinal mucosa by commensal intestinal microbes, with and without help from T cells. He has also shown a compartmentalisation between the mucosal and systemic Ig responses to commensals, since mucosal immune responses are driven locally in the mucosal compartment by dendritic cells that have sampled commensals at the epithelial surface. More recently his lab has developed methods of reversible colonisation of germ-free mice to allow intestinal colonisation with commensals and mucosal immune priming to be experimentally uncoupled, to address mucosal immune memory and the functional consequences of mucosal immune responses in host-microbial mutualism.

PD Dr. med. Camillo Ribi
PD Dr. med. Camillo Ribi

University Hospital Lausanne, Switzerland

Prof. Markus Neurath
Prof. Markus Neurath

University Hospital Erlangen, Germany

Prof. Jacob M. van Laar
Prof. Jacob M. van Laar

University Medical Centre Utrecht, Netherlands

Biosketch

Jacob M. van Laar is Professor at the Department of Rheumatology and Clinical Immunology at UMC Utrecht, the Netherlands. After obtaining his MD and PhD degrees at Leiden University, he specialised in Internal Medicine and Rheumatology in Leiden University Medical Center and worked at the Department of Rheumatology as clinical academic in various roles from 1997-2007, interrupted by a postdoctoral research fellowship at the National Institute of Arthritis and Musculoskeletal and Skin Diseases in Bethesda, USA. From 2007 until 2013 he held a Chair in Clinical Rheumatology at Newcastle University, and post as honorary consultant rheumatologist at The James Cook University Hospital, Middlesbrough, UK. He has been working as Professor of Rheumatology at UMC Utrecht since 1 November 2013. His main research interests involve clinical and pathogenetic aspects of systemic sclerosis and rheumatoid arthritis, aimed at improving the outcome of patients with rheumatic diseases by innovative clinical-translational research.

Dr. Patrick Omoumi
Dr. Patrick Omoumi

University Hospital Lausanne, Switzerland

Sponsors

Thanks to our sponsors for making this event possible!

Abbvie
BMS Logo
Pfizer Logo

Registration

The link for the online participation will be provided some days before the event.

SwissTech Convention Center

General Information

Please find here all organisational details about the event:

  • Access to venue
  • Hotel recommendations
  • Certifications
  • Prices etc.
  • COVID-19 protection measures

Get in Touch with the Organisation

Sina Reis-Balikcioglu

Comeed – Medical Conferences, Meetings & Education

Sina Reis-Balikcioglu

www.comeed.ch

Impressions 2019

With 145 participants the first edition of the Common Ground Meeting was a great succes! 

I appreciate the initianive of bringing different disciplines together – that definitly enables knowledge & experience sharing!

Prof. Axel Frinckh

University Hospital Geneva, Switzerland

Excellent meeting en ce qui concerne les thèmes abordés et discussions sur potentielles collaborations!

Dr. Valérie Pittet

University Center for Primary Care and Public Health, Lausanne, Switzerland

A very exciting and unique meeting, where experts from different disciplines exchange their newest insights and discuss common pathways of different diseases. Highly inspiring.

Dr. Christoph Schlapbach

Bern University Hospital, Switzerland